Pristinamycin

Modify Date: 2024-01-02 10:53:09

Pristinamycin Structure
Pristinamycin structure
Common Name Pristinamycin
CAS Number 270076-60-3 Molecular Weight 866.958
Density 1.4±0.1 g/cm3 Boiling Point 1202.1±65.0 °C at 760 mmHg
Molecular Formula C73H89N11O17 Melting Point N/A
MSDS N/A Flash Point 680.8±34.3 °C

 Use of Pristinamycin


Pristinamycin, produced by Streptomyces pristinaespiralis, is an orally active streptogramin-like antibiotic consisting of two chemically unrelated components: Pristinamycin I (PI) and Pristinamycin II (PII). Pristinamycin is highly active against many antibiotic-resistant pathogens, particularly Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant S. aureus (VRSA) and Enterococcus faecium (VREF)[1].

 Names

Name Pristinamycin
Synonym More Synonyms

 Pristinamycin Biological Activity

Description Pristinamycin, produced by Streptomyces pristinaespiralis, is an orally active streptogramin-like antibiotic consisting of two chemically unrelated components: Pristinamycin I (PI) and Pristinamycin II (PII). Pristinamycin is highly active against many antibiotic-resistant pathogens, particularly Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant S. aureus (VRSA) and Enterococcus faecium (VREF)[1].
Related Catalog
In Vitro In-vitro studies show pristinamycin to inhibit Staphylococci and Streptococci, including Erythromycin highly-resistant organisms, at a concentration of less than or equal to 0.78 mg/l[2].
In Vivo To study Pristinamycin activity in vivo, mice infected IP with C. psittaci. Mortality in the control group was 70%. Three groups of mice received 25 mg/kg, 50 mg/kg and 100 mg/kg Pristinamycin respectively. The antibiotic was active in the 100 mg/kg dosage which is the therapeutic dosage[3].
References

[1]. Meng J, et al. Improvement of pristinamycin I (PI) production in Streptomyces pristinaespiralis by metabolic engineering approaches. Synth Syst Biotechnol. 2017;2(2):130-136. Published 2017 Jun 8.

[2]. Maskell JP, et al. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin. Infection. 1988;16(6):365-370.

[3]. Orfila J, Haider F. Action de la pristinamycine sur les Chlamydia [Action of pristinamycin on Chlamydia]. Pathol Biol (Paris). 1984;32(5):443-445.

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 1202.1±65.0 °C at 760 mmHg
Molecular Formula C73H89N11O17
Molecular Weight 866.958
Flash Point 680.8±34.3 °C
Exact Mass 866.396301
LogP -0.45
Vapour Pressure 0.0±0.3 mmHg at 25°C
Index of Refraction 1.650

 Synonyms

Pristinamycin IA
Vernamycin B α
MFCD01778146
2-Pyridinecarboxamide, N-[(6R,9S,10R,13S,15aS,22S,24aS)-22-[[4-(dimethylamino)phenyl]methyl]-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxy-
N-{(6R,9S,10R,13S,15aS,22S,24aS)-22-[4-(Dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl}-3-hydroxy-2-pyridinecarboxamide
Ostreogrycin B
Streptogramin B
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Pristinamycin suppliers

Pristinamycin price